𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The role of conversion chemotherapy in initially non-optimal resectable liver metastases

✍ Scribed by T. Gruenberger

Publisher
Blackwell Publishing
Year
2009
Tongue
German
Weight
924 KB
Volume
41
Category
Article
ISSN
0001-544X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Assessing the optimal duration of chemot
Assessing the optimal duration of chemotherapy in patients with colorectal liver metastases
✍ Rebekah R. White; Lawrence H. Schwartz; Jose A. Munoz; Greer Raggio; William R. πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 124 KB

## Abstract ## Background and Objectives Few studies have addressed the optimal duration of chemotherapy, particularly prior to liver resection for colorectal liver metastases (CLM). The purpose of this retrospective analysis was to evaluate time to maximal response in patients receiving systemic 

Role of neoadjuvant chemotherapy in the
Role of neoadjuvant chemotherapy in the treatment of multiple colorectal metastases to the liver
✍ K. Tanaka; R. Adam; H. Shimada; D. Azoulay; F. LΓ©vi; H. Bismuth πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 117 KB πŸ‘ 2 views

## Abstract ## Background The role of neoadjuvant chemotherapy for patients with multiple (five or more) bilobar hepatic metastases irrespective of initial resectability is still under scrutiny. The purpose of this study was to compare the outcome of hepatectomy alone with that of hepatectomy afte

Role of intraoperative ultrasound in the
Role of intraoperative ultrasound in the screening of liver metastases from colorectal carcinoma: Initial experiences
✍ Dr. Antonio Russo; Giulio Sparacino; Sergio Plaja; Massimo Cajozzo; Carmelo la R πŸ“‚ Article πŸ“… 1989 πŸ› John Wiley and Sons 🌐 English βš– 813 KB

The aim of this study was to assess the utility of intraoperative ultrasound (IOUS) in the diagnosis and management of liver metastases from colorectal carcinoma. IOUS was performed on a consecutive series of 70 patients undergoing surgery for colorectal carcinoma, with follow-up ranging from 6 to 2